Difficulty: Medium
Average Score: 75%
Testbank
The nurse is working at an oncologist's office specializing in breast cancer. The nurse cares for individuals of varied ages, backgrounds, and stages of breast cancer. Which criteria are considered a priority when determining adjunct treatment in addition to surgery? Select all that apply.
Correct answer
A,C,D,F
Rationale
Stage of tumor is a priority criterion when determining adjunct treatment for breast cancer patients.
The stage of the tumor is crucial in guiding treatment decisions as it reflects the extent of the disease, helping to determine the likelihood of recurrence and the need for additional therapies such as chemotherapy or radiation in conjunction with surgery.
B: Cosmetic consequence does not directly influence the medical necessity of adjunct treatments, as the primary focus is on the effectiveness of treatment rather than aesthetic outcomes.
C: Presence of metastasis is important but is not the sole criterion; it serves as a consideration within the broader context of tumor staging rather than a standalone factor for adjunct treatment decisions.
D: Age can influence treatment options and patient tolerance, but it is not a primary criterion in determining adjunct treatments, which are more focused on cancer-specific factors like tumor stage.
E: Gender is generally not a determining factor for adjunct treatment in breast cancer, as treatment decisions are primarily based on the biological characteristics of the tumor rather than the patient's gender.
F: Sensitivity to estrogen is relevant for treatment planning, particularly for hormone receptor-positive cancers, but it is considered within the context of tumor characteristics and staging rather than as a standalone criterion for adjunct therapies.
The stage of the tumor is crucial in guiding treatment decisions as it reflects the extent of the disease, helping to determine the likelihood of recurrence and the need for additional therapies such as chemotherapy or radiation in conjunction with surgery.
B: Cosmetic consequence does not directly influence the medical necessity of adjunct treatments, as the primary focus is on the effectiveness of treatment rather than aesthetic outcomes.
C: Presence of metastasis is important but is not the sole criterion; it serves as a consideration within the broader context of tumor staging rather than a standalone factor for adjunct treatment decisions.
D: Age can influence treatment options and patient tolerance, but it is not a primary criterion in determining adjunct treatments, which are more focused on cancer-specific factors like tumor stage.
E: Gender is generally not a determining factor for adjunct treatment in breast cancer, as treatment decisions are primarily based on the biological characteristics of the tumor rather than the patient's gender.
F: Sensitivity to estrogen is relevant for treatment planning, particularly for hormone receptor-positive cancers, but it is considered within the context of tumor characteristics and staging rather than as a standalone criterion for adjunct therapies.